{"id":"https://openalex.org/W2906855438","doi":"https://doi.org/10.1182/blood-2018-99-110449","title":"Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to MRD-Negative Complete Remissions","display_name":"Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to MRD-Negative Complete Remissions","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2906855438","doi":"https://doi.org/10.1182/blood-2018-99-110449","mag":"2906855438"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-110449","doi":"https://doi.org/10.1182/blood-2018-99-110449","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110449","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066934816","display_name":"Eytan M. Stein","orcid":"https://orcid.org/0000-0001-8992-9390","observed_orcids":["https://orcid.org/0000-0001-8992-9390"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eytan M. Stein","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010057352","display_name":"Amir Tahmasb Fathi","orcid":"https://orcid.org/0000-0003-4907-6447","observed_orcids":["https://orcid.org/0000-0003-4907-6447"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir T. Fathi","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023917898","display_name":"Alice S. Mims","orcid":"https://orcid.org/0000-0002-8971-2199","observed_orcids":["https://orcid.org/0000-0002-8971-2199"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice S. Mims","raw_affiliation_strings":["Ohio State University Wexner Medical Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Wexner Medical Center, Columbus, OH","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045709974","display_name":"Keith William Pratz","orcid":"https://orcid.org/0000-0002-1284-8266","observed_orcids":["https://orcid.org/0000-0002-1284-8266"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith W. Pratz","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt-Ingram Center, VUMC, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Center, VUMC, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061495135","display_name":"Anthony Selwyn Stein","orcid":"https://orcid.org/0000-0002-1786-1398","observed_orcids":["https://orcid.org/0000-0002-1786-1398"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony S. Stein","raw_affiliation_strings":["City of Hope Medical Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013721199","display_name":"Eric S. Winer","orcid":"https://orcid.org/0000-0002-4515-8245","observed_orcids":["https://orcid.org/0000-0002-4515-8245"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric S. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061114123","display_name":"Christopher S. Seet","orcid":"https://orcid.org/0000-0002-4821-1400","observed_orcids":["https://orcid.org/0000-0002-4821-1400"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher S. Seet","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089395073","display_name":"Hartmut D\u00f6hner","orcid":"https://orcid.org/0000-0003-2116-5536","observed_orcids":["https://orcid.org/0000-0003-2116-5536"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hartmut D\u00f6hner","raw_affiliation_strings":["Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032549755","display_name":"Daniel Aaron Pollyea","orcid":"https://orcid.org/0000-0001-6519-4860","observed_orcids":["https://orcid.org/0000-0001-6519-4860"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A Pollyea","raw_affiliation_strings":["University of Colorado School of Medicine, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado School of Medicine, Aurora, CO","institution_ids":["https://openalex.org/I51713134","https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006561610","display_name":"James K. McCloskey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James K McCloskey","raw_affiliation_strings":["Hackensack University Medical Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack University Medical Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060015628","display_name":"Olatoyosi M. Odenike","orcid":"https://orcid.org/0000-0002-4027-4124","observed_orcids":["https://orcid.org/0000-0002-4027-4124"]},"institutions":[{"id":"https://openalex.org/I4390039251","display_name":"University of Chicago Medicine Comprehensive Cancer Center","ror":"https://ror.org/042wftp98","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210087865","https://openalex.org/I4390039251"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Olatoyosi Odenike","raw_affiliation_strings":["University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL","institution_ids":["https://openalex.org/I4390039251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046775582","display_name":"Bob L\u00f6wenberg","orcid":"https://orcid.org/0000-0001-8982-5217","observed_orcids":["https://orcid.org/0000-0001-8982-5217"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Bob Lowenberg","raw_affiliation_strings":["Erasmus University Medical Centre, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasmus University Medical Centre, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108882243","display_name":"Gert Jan Ossenkoppele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gert J. Ossenkoppele","raw_affiliation_strings":["VUMC Cancer Center, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VUMC Cancer Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067973814","display_name":"Prapti Arvind Patel","orcid":"https://orcid.org/0000-0002-8865-4492","observed_orcids":["https://orcid.org/0000-0002-8865-4492"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prapti A. Patel","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079953387","display_name":"Mikhail Roshal","orcid":"https://orcid.org/0000-0002-9585-0790","observed_orcids":["https://orcid.org/0000-0002-9585-0790"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikhail Roshal","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050311165","display_name":"Frederik Lersch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frederik Lersch","raw_affiliation_strings":["Celgene International, Boudry, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene International, Boudry, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082846098","display_name":"Salah Nabhan","orcid":"https://orcid.org/0009-0007-1645-9894","observed_orcids":["https://orcid.org/0009-0007-1645-9894"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Salah Nabhan","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048342090","display_name":"Sung E. Choe","orcid":"https://orcid.org/0000-0001-9140-4198","observed_orcids":["https://orcid.org/0000-0001-9140-4198"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sung Choe","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101784375","display_name":"Hongfang Wang","orcid":"https://orcid.org/0000-0002-1104-1540","observed_orcids":["https://orcid.org/0000-0002-1104-1540"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hongfang Wang","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109462199","display_name":"Lei Hua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lei Hua","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023808130","display_name":"Caroline Almon","orcid":"https://orcid.org/0009-0007-0852-3729","observed_orcids":["https://orcid.org/0009-0007-0852-3729"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Caroline Almon","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Cooper","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001124933","display_name":"Martin S. Tallman","orcid":"https://orcid.org/0000-0002-4367-6102","observed_orcids":["https://orcid.org/0000-0002-4367-6102"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin S. Tallman","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":22,"corresponding_author_ids":["https://openalex.org/A5023808130","https://openalex.org/A5048342090","https://openalex.org/A5050311165","https://openalex.org/A5071023119","https://openalex.org/A5082846098","https://openalex.org/A5101784375","https://openalex.org/A5109462199"],"corresponding_institution_ids":["https://openalex.org/I4210092565","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"560","last_page":"560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ivosidenib","display_name":"ivosidenib","score":0.9139999747276306},{"id":"https://openalex.org/keywords/enasidenib","display_name":"enasidenib","score":1.0},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.8190000057220459},{"id":"https://openalex.org/keywords/idh2-mutation","display_name":"IDH2 mutation","score":1.0},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9330000281333923},{"id":"https://openalex.org/keywords/newly-diagnosed-aml","display_name":"newly diagnosed AML","score":0.9580000042915344},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/consolidation-chemotherapy","display_name":"consolidation chemotherapy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8640000224113464},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8299999833106995},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.953000009059906},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.8809999823570251},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5170000195503235},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.49399998784065247},{"id":"https://openalex.org/keywords/co-mutations","display_name":"co-occurring mutations","score":0.6959999799728394},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2776059313","wikidata":"https://www.wikidata.org/wiki/Q21116031","display_name":"IDH2","level":5,"score":0.7884764671325684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7702232003211975},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.6992048621177673},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.555868923664093},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5079753994941711},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42820096015930176},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4152938723564148},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40733227133750916},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.36798641085624695},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3368862271308899},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08168303966522217},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.056041181087493896},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-110449","doi":"https://doi.org/10.1182/blood-2018-99-110449","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110449","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.699999988079071,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2128680685","https://openalex.org/W4366704913","https://openalex.org/W2084945856","https://openalex.org/W3586383","https://openalex.org/W4210828912","https://openalex.org/W4307264101","https://openalex.org/W2126817554","https://openalex.org/W1989246074","https://openalex.org/W2903060962","https://openalex.org/W2003059099"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Ivosidenib":[2,372,600],"(AG-120)":[3],"and":[4,14,43,78,194,301,339,355,362,365,378,395,403,439,455,492,516,537,559,591,607,621,645,815,837,1201],"enasidenib":[5,133,169,304,374,602,641],"(AG-221)":[6],"are":[7,99,159,268,531,572],"oral":[8],"inhibitors":[9],"of":[10,23,45,47,68,147,173,236,238,252,283,387,424,452,477,506,553,563,587,595,627,637,737,750,784,795,979,991,1003,1017,1031,1044,1059,1099,1111,1123,1138,1150,1163,1207,1217,1226],"mutant":[11,15],"IDH1":[12,360],"(mIDH1)":[13],"IDH2":[16,370],"(mIDH2),":[17],"respectively,":[18],"approved":[19],"for":[20,161,242,357,367,401,420,473,533,574,648],"the":[21,41,66,152,171,227,234,385,415,468],"treatment":[22,188],"relapsed/refractory":[24],"IDH-mutant":[25],"acute":[26],"myeloid":[27],"leukemia":[28],"(AML).":[29],"Here":[30],"we":[31],"report":[32],"updated":[33],"results":[34],"from":[35],"a":[36,224,231,271,422,475,545,578,625,660,1230],"phase":[37,86,662],"1":[38,87],"study":[39,88],"on":[40,165,247,384,733,746,780,791,975,987,999,1013,1027,1040,1055,1095,1107,1119,1134,1146,1159,1213,1229],"safety":[42,613],"efficacy":[44],"each":[46],"these":[48],"agents":[49],"when":[50],"combined":[51,375],"with":[52,57,92,101,114,123,270,293,303,337,344,359,369,376,412,435,443,488,497,555,565,589,597,605,615,631,650],"intensive":[53],"chemotherapy":[54],"in":[55,121,206,226,255,333,340,410,431,484,493,550,560,584,592,603,624,659],"patients":[56,91,142,176,288,336,343,358,368,411,418,434,442,448,457,463,471,487,496,502,510,518,524,536,542,576,630,649],"newly":[58,93,651],"diagnosed":[59,94,652],"AML,":[60],"as":[61,63,223],"well":[62,381],"data":[64,530],"regarding":[65],"rate":[67],"measurable":[69],"residual":[70],"disease":[71],"(MRD)-negative":[72],"complete":[73,157],"remissions":[74],"(CRs),":[75],"mutation":[76,218,622],"clearance":[77,219,623],"molecular":[79],"profiling.":[80],"METHODS:":[81],"In":[82,541],"this":[83,239],"open-label,":[84],"multicenter,":[85],"(NCT02632708),":[89],"eligible":[90],"mIDH1":[95,556,590],"or":[96,107,132,158,168,248,320,325,373,427,480,601,640,739,752,786,797,981,993,1005,1019,1033,1046,1061,1101,1113,1125,1140,1152,1165,1219],"mIDH2":[97,338,566],"AML":[98,314,438,491,654],"treated":[100],"induction":[102,377,515,606],"therapy":[103,149,454,609,647],"(daunorubicin":[104],"60":[105,538],"mg/m2/day":[106,110,117],"idarubicin":[108],"12":[109],"x":[111,118],"3":[112,663],"days":[113],"cytarabine":[115],"200":[116],"7":[119],"days)":[120],"combination":[122,604],"either":[124],"ivosidenib":[125,167,294,639],"500":[126],"mg":[127,135],"once":[128,136],"daily":[129,137],"(for":[130,138],"mIDH1)":[131],"100":[134],"mIDH2).":[139],"After":[140],"induction,":[141,643],"may":[143,163],"receive":[144],"\u22644":[145],"cycles":[146],"consolidation":[148,162,379,453,507,608,644],"while":[150],"continuing":[151],"mIDH":[153,186,632,653],"inhibitor.":[154],"Patients":[155],"who":[156,177,543],"ineligible":[160],"continue":[164],"maintenance":[166,459,512,520,646],"until":[170],"end":[172],"study.":[174],"For":[175],"proceed":[178],"to":[179,192,230,278,328,465,526,642],"allogeneic":[180],"hematopoietic":[181],"stem":[182],"cell":[183],"transplant":[184,193],"(HSCT),":[185],"inhibitor":[187],"is":[189,195,204,221,259],"discontinued":[190],"prior":[191],"not":[196],"resumed":[197],"post-transplant.":[198],"mIDH1/2":[199,228],"variant":[200],"allele":[201],"frequency":[202,386],"(VAF)":[203],"assessed":[205],"bone":[207,256],"marrow":[208,257],"mononuclear":[209],"cells":[210],"using":[211,261],"Digital":[212],"PCR":[213],"Technology":[214],"(Sysmex-Inostics":[215],"Inc).":[216],"IDH1/2":[217],"(IDH-MC)":[220],"defined":[222],"reduction":[225],"VAF":[229,529],"level":[232],"below":[233],"limit":[235],"detection":[237],"assay":[240],"(0.02-0.04%)":[241],"\u22651":[243,450,504],"on-treatment":[244],"time":[245],"point":[246],"after":[249,317,326,460,514,521],"Day":[250],"28":[251],"induction.":[253],"MRD":[254],"aspirates":[258],"analyzed":[260],"multi-parameter":[262],"flow":[263],"cytometry.":[264],"Baseline":[265],"co-occurring":[266,349],"mutations":[267,351],"identified":[269],"95-gene":[272],"next":[273],"generation":[274],"sequencing":[275],"panel":[276],"targeted":[277],"hematologic":[279,323,396],"malignancies.":[280],"RESULTS:":[281],"As":[282],"May":[284],"1,":[285],"2018,":[286],"134":[287],"had":[289],"been":[290],"treated:":[291],"47":[292],"(median":[295,305],"age":[296,306],"63":[297,307],"years,":[298,308],"range":[299,309],"24-76)":[300],"87":[302],"27-77;":[310],"Table":[311],"1).":[312],"Secondary":[313],"(sAML;":[315],"arising":[316],"myelodysplastic":[318],"syndrome":[319],"another":[321],"antecedent":[322],"disorder,":[324],"exposure":[327],"genotoxic":[329],"injury)":[330],"was":[331,380,429,482,548],"present":[332],"33/87":[334],"(38%)":[335],"16/47":[341],"(34%)":[342],"mIDH1.":[345],"The":[346,634],"most":[347],"frequent":[348],"baseline":[350],"were":[352,407,582],"DNMT3A,":[353,363],"NPM1":[354],"NRAS":[356],"mutations;":[361],"SRSF2":[364],"ASXL1":[366],"mutations.":[371],"tolerated,":[382],"based":[383],"grade":[388],"\u22653":[389],"non-hematologic":[390],"adverse":[391],"events":[392],"(Table":[393,398,445,499,557,567],"2)":[394],"recovery":[397,406],"3).":[399],"Times":[400],"ANC":[402],"platelet":[404],"count":[405],"nominally":[408],"longer":[409],"sAML.":[413],"Among":[414,467],"41":[416],"ivosidenib-treated":[417,535],"evaluable":[419,472],"efficacy,":[421,474],"response":[423,476],"CR,":[425,478,546],"CRi":[426],"CRp":[428,481],"achieved":[430,483,544],"26/28":[432],"(93%)":[433],"de":[436,489],"novo":[437,490],"6/13":[440],"(46%)":[441],"sAML":[444,498],"4).":[446,500],"Twenty-one":[447],"received":[449,458,503,511,519],"cycle":[451,505],"11":[456,517],"consolidation.":[461,522],"Seventeen":[462],"proceeded":[464,525],"HSCT.":[466,527],"77":[469],"enasidenib-treated":[470,539],"CRi,":[479],"33/45":[485],"(73%)":[486],"20/32":[494],"(63%)":[495],"Thirty-seven":[501],"therapy,":[508],"6":[509],"directly":[513],"Thirty-three":[523],"Longitudinal":[528],"available":[532,573],"31":[534],"patients.":[540],"IDH-MC":[547],"observed":[549,583],"41%":[551],"(9/22)":[552],"those":[554,564,588,596],"5)":[558],"30%":[561],"(11/37)":[562],"6).":[568],"Flow":[569],"cytometry":[570],"assessments":[571],"21":[575],"achieving":[577],"CR:":[579],"MRD-negative":[580,619],"CRs":[581],"89%":[585],"(8/9)":[586],"58%":[593],"(7/12)":[594],"mIDH2.":[598],"CONCLUSION:":[599],"has":[610],"an":[611,734,747,781,792,976,988,1000,1014,1028,1041,1056,1096,1108,1120,1135,1147,1160,1214],"acceptable":[612],"profile":[614],"robust":[616],"remission":[617],"rates,":[618],"CRs,":[620],"population":[626],"older,":[628],"high-risk":[629],"AML.":[633],"clinical":[635],"benefit":[636],"adding":[638],"will":[655],"be":[656],"further":[657],"evaluated":[658],"randomized":[661],"trial.":[664],"Disclosures":[665],"Stein:":[666],"Celgene:":[667,688,715,777,833,919,943,1104,1175],"Consultancy;":[668,670,673,675,677,759,776,809,811,824,826,828,830,832,844,846,848,858,1009,1074],"Agios:":[669,696,720,767,819,893,924,1010,1172],"Daiichi":[671],"Sankyo:":[672],"Bayer:":[674,692],"Pfizer:":[676,825,960,970,1024,1073,1092],"Novartis:":[678,755,853,869,878],"Consultancy.":[679,756,860],"DiNardo:Karyopharm:":[680],"Other:":[681,685,689,693,698,703,813,835],"Advisory":[682,686,690,694,699,704],"role;":[683,687,691,695,700],"Medimmune:":[684],"Consultancy,":[697,702,709,713,716,726,744,761,771,778,820,834,850,854,862,865,870,879,884,891,894,898,901,904,907,910,913,917,920,925,938,941,944,950,953,958,964,968,985,997,1011,1025,1050,1077,1082,1093,1105,1117,1132,1144,1157,1196],"AbbVie:":[701,760,890,900,1049],"role.":[705],"Fathi:Jazz:":[706],"Honoraria;":[707,710,714,727,863,885,892,895,899,902,905,908,911,914,918,926,939,942,951,959,965,969,1197],"Takeda:":[708],"Seattle":[711,948,966],"Genetics:":[712,949,967],"Honoraria,":[717,721,866,871,880,921,945,954,1070,1089],"Research":[718,722,762,765,768,772,800,821,851,855,867,872,876,881,888,922,930,935,946,955,961,971,1022,1036,1051,1090,1128,1170,1173,1176,1180,1183,1186,1190],"Funding;":[719,723,763,766,769,822,852,856,868,873,877,882,889,923,931,936,947,956,962,1023,1037,1052,1091,1129,1171,1174,1177,1181,1184,1187],"Boston":[724],"Biomedical:":[725],"Astellas:":[728,770,831,909],"Honoraria.":[729],"Mims:Abbvie":[730],"Pharmaceuticals:":[731,743,875,887,897,916,1065,1069,1076,1081,1156],"Membership":[732,745,779,790,974,986,998,1012,1026,1039,1054,1094,1106,1118,1133,1145,1158,1212,1228],"entity's":[735,748,782,793,977,989,1001,1015,1029,1042,1057,1097,1109,1121,1136,1148,1161,1215],"Board":[736,749,783,794,978,990,1002,1016,1030,1043,1058,1098,1110,1122,1137,1149,1162,1216,1223],"Directors":[738,751,785,796,980,992,1004,1018,1032,1045,1060,1100,1112,1124,1139,1151,1164,1218],"advisory":[740,753,787,798,982,994,1006,1020,1034,1047,1062,1102,1114,1126,1141,1153,1166,1220],"committees;":[741,754,788,983,995,1007,1048,1103,1115,1142,1154,1167,1221],"Agios":[742],"Pratz:Boston":[757],"Scientific:":[758],"Millenium/Takeda:":[764],"Funding.":[773,801,972,1191],"Savona:Boehringer":[774],"Ingelheim:":[775],"Incyte:":[789,1143],"committees,":[799,1021,1035,1127],"Stein:Celgene:":[802],"Speakers":[803,806,1066,1071,1078,1083],"Bureau;":[804,1067,1072,1079,1084],"Amgen:":[805,827,903,912],"Bureau.":[807],"Stone:AbbVie:":[808],"Merck:":[810],"Argenx:":[812,984],"Data":[814,836],"Safety":[816,838],"Monitoring":[817,839],"Board;":[818],"Sumitomo:":[823],"Cornerstone:":[829],"Board,":[840],"Steering":[841],"Committee;":[842],"Otsuka:":[843],"Jazz:":[845,883,957],"Fujifilm:":[847],"Arog:":[849],"Ono:":[857],"Orsenix:":[859],"D\u00f6hner:Astellas:":[861],"Sunesis:":[864,952],"AROG":[874,886],"Astex":[896,915],"Celator:":[906,963],"Bristol":[927,932],"Myers":[928,933],"Squibb:":[929,934],"Janssen:":[937,940,1182],"Pollyea:Celgene:":[973],"Celyad:":[996],"Gilead:":[1008],"Curis:":[1038],"Karyopharm:":[1053],"committees.":[1063],"McCloskey:Amgen":[1064],"Celgene":[1068],"Takeda":[1075],"Jazz":[1080,1155],"COTA:":[1085],"Equity":[1086],"Ownership.":[1087],"Odenike:ABBVIE:":[1088],"CTI/Baxalta:":[1116],"Dava":[1130],"Oncology:":[1131],"Oncotherapy":[1168],"Science:":[1169],"NS":[1178],"Pharma:":[1179],"Astex:":[1185],"Gilead":[1188],"Sciences:":[1189],"Lowenberg:Clear":[1192],"Creek":[1193],"Bio":[1194],"Ltd:":[1195],"Chairman":[1198],"Scientific":[1199],"Committee":[1200],"Member":[1202],"Executive":[1203],"Committee,":[1204],"European":[1205],"School":[1206],"Hematology":[1208],"(ESH,":[1209],"Paris,":[1210],"France):":[1211],"Editorial":[1222],"\"International":[1224],"Journal":[1225],"Hematology\":":[1227]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":23},{"year":2019,"cited_by_count":24}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}